1. Home
  2. CRMT vs MIST Comparison

CRMT vs MIST Comparison

Compare CRMT & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo America's Car-Mart Inc

CRMT

America's Car-Mart Inc

HOLD

Current Price

$21.38

Market Cap

208.2M

ML Signal

HOLD

Logo Milestone Pharmaceuticals Inc.

MIST

Milestone Pharmaceuticals Inc.

HOLD

Current Price

$1.70

Market Cap

176.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRMT
MIST
Founded
1981
2003
Country
United States
Canada
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.2M
176.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CRMT
MIST
Price
$21.38
$1.70
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$37.00
$8.50
AVG Volume (30 Days)
89.3K
2.2M
Earning Date
03-05-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,381,482,000.00
N/A
Revenue This Year
$2.41
N/A
Revenue Next Year
$4.65
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.01
N/A
52 Week Low
$17.78
$0.63
52 Week High
$62.72
$3.06

Technical Indicators

Market Signals
Indicator
CRMT
MIST
Relative Strength Index (RSI) 30.00 34.51
Support Level $20.93 $1.70
Resistance Level $26.75 $1.89
Average True Range (ATR) 1.43 0.10
MACD -0.58 -0.01
Stochastic Oscillator 5.45 2.86

Price Performance

Historical Comparison
CRMT
MIST

About CRMT America's Car-Mart Inc

America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and, in the majority of cases, a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Share on Social Networks: